Related Experiment Video
Updated: Jan 18, 2026
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
Fraction-based Linear Extrapolation (FLEX) Method for Predicting Human Pharmacokinetic Clearance: Advanced Allometric
Yuki Umemori1, Koichi Handa2, Saki Yoshimura1
1Axcelead Tokyo West Partners, Inc. Translational Science, Discovery DMPK, Hino-Shi, Tokyo, 191-0065, Japan.
Purpose:
Accurate prediction of human clearance (CL) is essential in early drug development. Single Species Scaling (SSS) using rat pharmacokinetic (PK) data, particularly with unbound plasma fraction (fu,plasma), is widely used. However, its accuracy declines for compounds with extremely low fu,plasma, and no systematic method has addressed this limitation.
Methods:
We developed a new approach, called Fraction-based Linear EXtrapolation SSS (FLEX-SSS fu Rat), which switches between SSS fu Rat and SSS Rat formulas based on an optimized fu threshold. The threshold and scaling coefficients were derived using a training set of 200 compounds. Additionally, a random forest (RF) machine learning model was built using molecular descriptors. Both models were validated using an external dataset of 62 compounds.
Results:
All five predictive models showed comparable performance; among them, the consensus model combining FLEX-SSS fu Rat and RF yielded the best result: 40.3% within 2-fold error, only 16.1% above 5-fold, and GMFE of 2.7.
Conclusion:
This study is the first to systematically validate SSS fu Rat using an independent dataset. The integration of threshold-based allometry and machine learning enabled more accurate human CL prediction, supporting informed decisions in first-in-human dose selection.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
08:59An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Related Concept Videos
01:17Clearance Models: Noncompartmental Models
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
00:56One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...